Jaguar Health (JAGX) Current Leases (2017 - 2026)
Jaguar Health's (JAGX) quarterly Current Leases came in at $261000.0 in Q1 2026, down 4.4% year-on-year from $273000.0 in Q1 2025, and up 35.94% on a QoQ basis from $192000.0 in Q4 2025.
Jaguar Health (JAGX) Current Leases (2017 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 10 years of Current Leases data on file, last reported at $261000.0 in Q1 2026.
- On a quarterly basis, Current Leases fell 4.4% year-over-year to $261000.0 in Q1 2026; TTM through Mar 2026 was $261000.0, a 4.4% decrease from a year earlier, with the FY2025 full-year figure at $192000.0, down 35.79% from the prior year.
- Current Leases for Q1 2026 stood at $261000.0, up from $192000.0 in the prior quarter.
- Over the last five years, Current Leases for JAGX reached as high as $526000.0 in Q3 2023 and fell as low as $192000.0 in Q4 2025.
- Historically, Current Leases has averaged $367176.5 across 5 years, with a median of $368000.0 in 2024.
- Across the five-year window, Current Leases soared 101.25% in 2022 and sank 41.79% in 2025, its largest moves.
- Year by year, Current Leases stood at $483000.0 in 2022, then slipped by 27.95% to $348000.0 in 2023, then decreased by 14.08% to $299000.0 in 2024, then sank by 35.79% to $192000.0 in 2025, then surged by 35.94% to $261000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $261000.0 in Q1 2026, $192000.0 in Q4 2025, and $226000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,810.93 Bn | 1,810.87 Bn | - | - |
| 2 | Akari Therapeutics | 997.56 Bn | 997.56 Bn | - | - |
| 3 | BeOne Medicines | 475.29 Bn | 470.50 Bn | 1.35 Bn | 20.58 Mn |
| 4 | Vertex Pharmaceuticals | 124.40 Bn | 117.15 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 72.15 Bn | 63.40 Bn | 3.31 Bn | 720.00 Mn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.26 Bn | 49.08 Bn | 1.41 Bn | 11.00 Mn |
| 8 | Alnylam Pharmaceuticals | 38.21 Bn | 35.20 Bn | 959.66 Mn | 45.66 Mn |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - | 16.61 Mn |
| 10 | Jaguar Health | 513,982.75 | -9.55 Mn | 19.11 Mn | 261,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 273,000.00 |
| Dec 31, 2024 | 299,000.00 |
| Sep 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 526,000.00 |
| Jun 30, 2023 | 515,000.00 |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 483,000.00 |
| Sep 30, 2022 | 418,000.00 |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 240,000.00 |
| Sep 30, 2021 | 297,000.00 |
| Jun 30, 2021 | 199,000.00 |